Interlaboratory variability of CD34+ stem cell enumeration. A pilot study to national external quality assessment within the Czech Republic

International Journal of Laboratory Hematology

Volumn 32, Issue 6 PART 1, 2010, Pages

  Lysak D ^a   Kalina, T ^b   Martinek J ^c   PikalovA Z ^d   VokurkovA D ^e   JareSovA M ^f   Marinov, I ^g   OndrejkovA A ^h   Spacek M ⁱ   Stehlikova O ^j  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c Department of Pathology   (Czech Republic)

^d UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^e UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^h Department of Pulmonology   (Czech Republic)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j UNIVERSITY HOSPITAL BRNO   (Czech Republic)

more..

Author keywords

CD34+ cells; enumeration; interlaboratory; ISHAGE; survey; variability

Indexed keywords

ARTICLE; CD34 SELECTION; CELL COUNT; CLINICAL PROTOCOL; CONTROLLED STUDY; CZECH REPUBLIC; FLOW CYTOMETRY; HEALTH SURVEY; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; PILOT STUDY; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM; STANDARDIZATION; STEM CELL;

ANTIGENS, CD34; CZECH REPUBLIC; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LABORATORIES; LABORATORY TECHNIQUES AND PROCEDURES; LEUKOCYTE COUNT; PILOT PROJECTS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 78349294494     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01244.x     Document Type: Article

References (23)

1. Barnett D., Granger V., Storie I., Peel J., Pollitt R., Smart T., &, Reilly J.T., (1998) Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK-NEQAS) using a unique stable whole blood preparation. British Journal Haematology 102, 553 - 565.
2. Barnett D., Granger V., Whitby L., Storie I., &, Reilly J.T., (1999) Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward. British Journal Haematology 106, 1059 - 1062.
3. Barnett D., Granger V., Kraan J., Whitby L., Reilly T., Papa S., &, Gratama J.W., (2000) Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). British Journal Haematology 108, 784 - 792.
4. Chang A., &, Ma D.D.F., (1996) The influence of flow cytometric gating strategies on the standardization of CD34+ quantitation: an Australian multi-centre study. Australasian BMT Scientists Study Group. Journal of Hematotherapy 5, 606 - 616.
5. Chin-Yee I., Anderson L., Keeney M., &, Sutherland D.R., (1997) Quality assurance of stem cell enumeration by flow cytometry. Cytometry 30, 296 - 303.
6. Gratama J.W., Kraan J., Levering W., Van Bockstaele D.R., Rijkers G., &, Van der Schoot C.E., (1997) Analysis of variation in the results of CD34+ hematopoietic progenitor cell enumeration in a multicentric study. Cytometry 30, 109 - 117.
7. Gratama J.W., Orval A., Barnett D., Brando B., Huber A., Canossy G., Johnsen H.E., Keeny M., Marti G.E., Preijers F., Rothe G., Serke S., Sutherland D.R., Van der Schoot C.E., Schmitz G., &, Papa S., (1998) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry 34, 128 - 142.
8. Gratama J.W., Braakman E., Kraan J., Lankheet P., Levering W.H.B.M., Van den Beemd M.W.M., Van der Schoot C.E., Wijermans P., &, Preijers F., (1999) Comparison of single and dual-platform assay formats for CD34+ hematopoietic progenitor cell enumeration. Clinical and Laboratory Haematology 21, 337 - 346.
9. Gratama J.W., Kraan J., Keeney M., Sutherland D.R., Granger V., &, Barnett D., (2003) Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 5, 55 - 65.
10. Johnson H.E., for the Nordic Myeloma Study Group Laboratories. (1995) Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Journal of Hematotherapy 4, 21 - 28.
11. Levering W.H.B.M., Preijers F.W.M.B., Van Wieringen W.N., Kraan J., Van Bedra W.A.M., Sintnicolaas K., Van Rhenen D.J., &, Grahama J.W., (2007) Flow cytometric CD34+ stem cell enumeration: lessons from nine years′ external duality assessment within the Benelux countries. Cytometry 72B, 178 - 188.
12. Lewis I.D., Rawling T., Dyson P.G., Haylock D.N., Juttner C.A., &, To L.B., (1996) Standardization of the CFU-GM assay using hematopoietic growth factors. Journal of Hematotherapy 5, 625 - 630.
13. Lioznov M.V., Freiberger P., Kröger N., Zander A.R., &, Fehse B., (2005) Aldehyde dehydrogenase activity as a marker fort he quality of hematopoietic stem cell transplant. Bone Marrow Transplantation 35, 909 - 914.
14. Lumley M.A., Burgess R., Billingham L.J., McDonald D.F., &, Milligan D.W., (1997) Colony counting is a major source of variation in CFU-GM results between centres. British Journal Haematology 97, 481 - 484.
15. Mehta J., Powles R., Treleaven J., Kulkarni S., Horton C., &, Singhal S., (1997) Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome. Blood 90, 3808 - 3810.
16. Pecora A.L., (1999) Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients. Bone Marrow Transplantation 23, S7 - S12.
17. Pecora A.L., Preti R.A., Gleim G.W., Jennis A., Zahos K., Cantwell S., Doria L., Isaacs R., Gillio A.P., Michelis M.A., &, Brochstein J.A., (1998) CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem cell recipients. Journal of Clinical Oncology 16, 2093 - 2104.
18. Serke S., Säuberlich S., &, Huhn D., (1991) Multiparameter flow-cytometrical quantitation of circulating CD34+ cells: correlation to the quantitation of circulating haematopoietic progenitor cells by in vitro colony-assay. British Journal Haematology 77, 453 - 459.
19. Shpall E.J., Champlin R., &, Glaspy J.A., (1998) Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biology of Blood and Marrow Transplantation 4, 84 - 92.
20. Siena S., Bregni M., Brando B., Belli N., Ravagnani F., Gandola L., Stern A.C., Lansdorp P.M., Bonadonna G., &, Gianni A.M., (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77, 400 - 409.
21. Stewart A.K., Imrie K., Keating A., Anania S., Nayar R., &, Sutherland D.R., (1995) Optimizing the CD34+ Thy-1+ stem cell content of peripheral blood collections. Experimental Hematology 23, 1619 - 1627.
22. Sutherland D.R., Anderson L., Keeney M., Nayar R., &, Chin-Yee I., (1996) The ISHAGE guidelines for CD34+ determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. Journal of Hematotherapy 5, 213 - 226.
23. Wunder E., Sovolat H., Fritsch G., Silvestri F., Henon P., &, Serke S., (1992) Report on the European workshop on peripheral blood stem cell determination and standardization - Mulhouse, France. Journal of Hematotherapy 1, 131 - 142.